Company Management

SphingoTec

Biotechnology Research De 20 employees

Employees: 20
Contacts: 1
Emails: 1

www.sphingotec.com LinkedIn Crunchbase

SphingoTec Overview

Headquarters: De
Phone Number: Available in AeroLeads
Website: www.sphingotec.com
Industry: Biotechnology Research
Employees: 20
Founded: 2002
Funding: 5.5M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biomarker discovery Acute care diagnostics Sepsis

About SphingoTec

SphingoTec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to support patient management and provide guidance for treatment strategies. Furthermore, sphingotec develops biomarkers for the prediction of health risks, such as obesity, cardiovascular diseases and breast cancer, in order to support prevention strategies. SphingoTec GmbH was established in 2002 by Dr. Andreas Bergmann was one of the founders of B.R.A.H.M.S. AG. As former Chief Research Officer, he was responsible for the development of the “gold standard” sepsis biomarker Procalcitonin (B.R.A.H.M.S. PCT™).

SphingoTec Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

SphingoTec Org Chart

Sample employees and titles

Name	Title	Location	Contact
Gerald Moeller	Chairman Mult	Frankfurt Rhine-main Metropolitan Area, Germany	Email
Rainer Strohmenger	Managing Partner at Wellington Partners		View
Ruxandra Lenz	Head of Marketing and Communications at Sphingotec		View
Dr. H.c. Samuel Voetter	Founder and Deputy Chairman of the Supervisory Board of Wirmachendruck Gmbh		View